US Regulatory Affairs Certification (RAC) Practice Exam

The section that addresses administrative issues related to human subjects is found in 21 CFR parts 100s. This part outlines the regulations and guidelines that govern the protection of human subjects involved in clinical research. It includes provisions for ensuring informed consent, ethical considerations, and the roles and responsibilities of institutional review boards (IRBs). These regulations are crucial for safeguarding the rights and welfare of participants in studies, which is a fundamental aspect of research involving human subjects.

In contrast, the other options target specific areas of regulatory requirements that do not primarily address human subject protections. For instance, 21 CFR 814 pertains to the approval process for new medical devices, while 21 CFR 807 focuses on the registration and listing of devices. Additionally, 21 CFR parts 200s typically deal with the reporting and administrative requirements related to drugs. Therefore, the emphasis on administrative issues surrounding human subjects is distinctly covered in the 21 CFR parts 100s.